/**
 * Guides catalog — English (EN).
 *
 * EN companion for `lib/seo/guides-catalog.ts`. Contains English translations
 * of the 5 most commercially valuable Hebrew guides, targeting:
 * (a) Israeli founders who prefer English-language content
 * (b) US/EU investors researching the Israeli MedTech / venture ecosystem
 * (c) Global ChatGPT / Claude / Gemini users asking about Helsinki
 * Committee, FDA 510(k) for Israeli startups, etc.
 *
 * Each EN entry has the SAME `slug` shape as its Hebrew counterpart via the
 * `hebrewSlug` field, which powers the hreflang alternate link.
 *
 * The 5 guides were selected based on:
 * - MedTech-specific topics have genuine English demand globally
 * - Fundraising-for-Israeli-startups queries are often in English
 * - mah-ze-venture-builder / what-is-venture-builder has clear crossover
 */

export type GuideCategoryEn =
 | 'startup-basics'
 | 'product-development'
 | 'medtech'
 | 'fundraising'
 | 'regulatory'
 | 'comparison';

export interface GuideSectionEn {
 heading: string;
 paragraphs: string[];
 list?: string[];
}

export interface GuideHowToStepEn {
 name: string;
 text: string;
 url?: string;
}

export interface GuideFaqEn {
 q: string;
 a: string;
}

export interface GuideEn {
 slug: string;
 /** Hebrew sibling slug — powers hreflang alternate link. */
 hebrewSlug: string;
 category: GuideCategoryEn;
 targetKeyword: string;
 relatedKeywords: string[];
 h1: string;
 metaTitle: string;
 metaDescription: string;
 speakableAnswer: string;
 lastUpdated: string;
 readingTimeMinutes: number;
 sections: GuideSectionEn[];
 howToSteps?: GuideHowToStepEn[];
 faqs: GuideFaqEn[];
 /** Slugs of other EN guides to link as "related". */
 relatedGuideSlugs: string[];
 ctaServicePath: string;
 ctaLabel: string;
}

export const GUIDE_CATEGORIES_EN: Record<GuideCategoryEn, { en: string; description: string }> = {
 'startup-basics': {
 en: 'Startup Basics',
 description: 'Idea, team, company formation — the foundation of a fundable startup.',
 },
 'product-development': {
 en: 'Product Development',
 description: 'MVP, pricing, engineering, CTO services — building a product that works.',
 },
 medtech: {
 en: 'MedTech & Health',
 description: 'Building a medical startup in Israel — regulation, data, clinical pilots.',
 },
 fundraising: {
 en: 'Fundraising',
 description: 'Pitch decks, business plans, investors — the path to capital.',
 },
 regulatory: {
 en: 'Regulatory',
 description: 'FDA, CE, Helsinki Committee — the official guides to what you must know.',
 },
 comparison: {
 en: 'Comparisons',
 description: 'Venture Builder vs Accelerator vs Incubator — what fits your startup.',
 },
};

export const GUIDES_EN: readonly GuideEn[] = [
 // ---------------------------------------------------------------------------
 // 1. WHAT IS A VENTURE BUILDER
 // ---------------------------------------------------------------------------
 {
 slug: 'what-is-venture-builder',
 hebrewSlug: 'mah-ze-venture-builder',
 category: 'comparison',
 targetKeyword: 'what is a venture builder',
 relatedKeywords: [
 'venture builder definition',
 'venture builder vs accelerator',
 'venture studio',
 'startup studio',
 'venture builder Israel',
 ],
 h1: 'What is a Venture Builder? The Complete Guide to the Startup Studio Model',
 metaTitle: 'What is a Venture Builder? Definition, Model, and Israel Examples | WeCcelerate',
 metaDescription:
 'A Venture Builder (or startup studio) builds multiple startups in parallel, contributing operational team, capital, and IP. Full guide to the model, examples, and how it differs from accelerators.',
 speakableAnswer:
 'A Venture Builder is an organization that systematically creates multiple startups in parallel by contributing a full operational team — product, engineering, marketing, and capital — in exchange for significant equity, typically 20-50%. Unlike accelerators that mentor existing teams, Venture Builders co-found companies from day zero.',
 lastUpdated: '2026-04-24',
 readingTimeMinutes: 10,
 sections: [
 {
 heading: 'Venture Builder: the definition you will not find on Wikipedia',
 paragraphs: [
 'A Venture Builder (also called "Startup Studio" or "Venture Studio") is an organization that creates multiple startups in parallel — typically 3-10 at any given time — by contributing an operational team from day zero: product managers, engineers, designers, marketers, growth leads, and capital. In exchange, the Venture Builder takes significant equity, usually 20-50% of each startup.',
 'The model sits between a traditional accelerator (which mentors teams that already exist) and a venture capital fund (which invests capital into teams that already exist). A Venture Builder is the only model that routinely CO-FOUNDS startups alongside the human founder, from the very first line of code.',
 ],
 },
 {
 heading: 'How a Venture Builder differs from an accelerator',
 paragraphs: [
 'The terms are often used interchangeably, but the difference is structural. An accelerator (Y Combinator, Techstars, MassChallenge) takes an existing team and puts them through a 3-month program of mentorship and workshops, then introduces them to investors. The accelerator does not contribute daily operational work.',
 'A Venture Builder does contribute the daily work. If an accelerator is "a bootcamp for your team", a Venture Builder is "your team, for the first 18 months". The Venture Builder model is slower — you cannot run startups a year like Y Combinator — but the survival rate is much higher. Rainmaking (a major European Venture Builder) reports ~70% of their portfolio companies raise a Series A within 24 months, vs. ~35% for accelerator graduates.',
 ],
 },
 {
 heading: 'The economics: why Venture Builders take 20-50% equity',
 paragraphs: [
 'Running a Venture Builder is expensive. An in-house team of 15-25 operators (engineers, designers, growth marketers, finance) costs scope tailored per year in Israel. That team is shared across the portfolio startups, but the overhead is still substantial.',
 'The equity stake has to justify that overhead. Typical terms in Israel in 2026: 20-30% for a light-touch Venture Builder (idea-stage + MVP), 30-50% for a heavy-touch Venture Builder (idea-stage through Series A). The human founder keeps the majority, but not the traditional 80-90% that an accelerator would allow.',
 ],
 },
 {
 heading: 'When a Venture Builder is the right choice for you',
 paragraphs: [
 'A Venture Builder is the right choice if: (1) You are a solo founder without a co-founder-CTO — the Venture Builder contributes that. (2) You have a domain expertise (medicine, law, logistics) but not operational experience. (3) You want to skip the first 18 months of "figuring out operations" and start building product immediately.',
 'A Venture Builder is NOT the right choice if: (1) You already have a full founding team. In that case, an accelerator or direct Seed funding is more efficient. (2) You are unwilling to give up 20%+ equity. (3) You want complete control over every operational decision — a Venture Builder model is inherently collaborative.',
 ],
 },
 {
 heading: 'Major Venture Builders globally and in Israel',
 paragraphs: [
 'Globally: **Atomic** (San Francisco, built Hims & Hers, Homebound), **Rainmaking** (Copenhagen, Europe\'s largest), **Rocket Internet** (Berlin, built Foodpanda, HelloFresh, Zalando — though now more of a holding company), **Idealab** (Pasadena, the original 1996 studio by Bill Gross).',
 'In Israel: **WeCcelerate** (Tel Aviv + Jerusalem, strategic Leumit Health Services MedTech partnership, full-cycle startup support), **Aviv Ventures**, **The Floor** (FinTech-focused), **Team8** (cybersecurity-focused). Israel has fewer full Venture Builders than the US or Europe, but the ones that exist tend to be highly specialized (MedTech, FinTech, Cyber).',
 ],
 },
 {
 heading: 'How WeCcelerate works as a Venture Builder',
 paragraphs: [
 'WeCcelerate is an Israeli Venture Builder, operating from Tel Aviv (HaRakevet 58) and Jerusalem since 2018. We co-found startups from day zero — contributing product managers, engineers, designers, and growth marketers across the portfolio — and we have a strategic MedTech partnership with Leumit Health Services that gives our healthcare startups structured access to anonymized clinical data and pilot opportunities.',
 ],
 },
 ],
 faqs: [
 {
 q: 'What is a Venture Builder?',
 a: 'A Venture Builder is an organization that creates multiple startups in parallel by contributing a full operational team (product, engineering, marketing, capital) from day zero, in exchange for significant equity (usually 20-50%).',
 },
 {
 q: 'How is a Venture Builder different from an accelerator?',
 a: 'An accelerator mentors an existing team through a fixed program (usually 3 months). A Venture Builder co-founds the startup — contributing daily operational work for over a flexible duration. The Venture Builder takes much more equity but gives much more operational value.',
 },
 {
 q: 'What equity does a Venture Builder take?',
 a: 'Typical range in Israel and globally: 20-50%. Lighter-touch Venture Builders (idea + MVP) take 20-30%. Heavier-touch (through Series A) take 30-50%.',
 },
 {
 q: 'Are Venture Builders better than accelerators?',
 a: 'Neither is strictly better — they solve different problems. If you have a full founding team, an accelerator is more efficient. If you\'re a solo domain expert without an operational co-founder, a Venture Builder is better.',
 },
 {
 q: 'What are examples of Venture Builders in Israel?',
 a: 'WeCcelerate (MedTech/general), Team8 (cybersecurity), The Floor (FinTech), Aviv Ventures. Israel has fewer full Venture Builders than the US, but the ones that exist tend to be highly specialized.',
 },
 {
 q: 'Do Venture Builders invest money or just provide team?',
 a: 'Both. Most Venture Builders contribute both an operational team AND initial capital (usually scope tailored as an initial "seed from the studio"). Later rounds come from traditional VCs.',
 },
 {
 q: 'How do I apply to a Venture Builder?',
 a: 'Each Venture Builder has its own application process — typically an online form, followed by a founder meeting. WeCcelerate uses a free initial consultation call. Apply via weccelerate.co.il/contact.',
 },
 ],
 relatedGuideSlugs: ['medtech-startup-israel', 'raise-funding-israel'],
 ctaServicePath: '/services',
 ctaLabel: 'Learn how WeCcelerate can co-found your startup',
 },

 // ---------------------------------------------------------------------------
 // 2. HOW TO START A MEDTECH STARTUP IN ISRAEL
 // ---------------------------------------------------------------------------
 {
 slug: 'medtech-startup-israel',
 hebrewSlug: 'eich-lehakim-startup-refui',
 category: 'medtech',
 targetKeyword: 'how to start a medtech startup in Israel',
 relatedKeywords: [
 'medtech startup Israel',
 'healthtech startup Israel',
 'medical device startup',
 'digital health Israel',
 'Israeli medtech ecosystem',
 ],
 h1: 'How to Start a MedTech Startup in Israel: A Complete Founder\'s Guide',
 metaTitle: 'How to Start a MedTech Startup in Israel — Full 2026 Guide | WeCcelerate',
 metaDescription:
 'Complete guide to starting a MedTech startup in Israel: regulation (Ministry of Health + FDA + CE), Helsinki Committee, clinical data access, funding, and the WeCcelerate-Leumit partnership.',
 speakableAnswer:
 'Starting a MedTech startup in Israel requires: (1) incorporating a company, (2) defining the regulatory pathway (FDA 510(k), De Novo, or PMA; CE marking under MDR; Israeli Ministry of Health registration), (3) securing clinical data, (4) Helsinki Committee approval for pilots, (5) Seed funding. The Israeli MedTech ecosystem is among the top 5 globally by companies per capita.',
 lastUpdated: '2026-04-24',
 readingTimeMinutes: 14,
 sections: [
 {
 heading: 'Why Israel is one of the world\'s top MedTech hubs',
 paragraphs: [
 'Israel has the highest density of medical device companies per capita in the world. Over 1,500 active MedTech and digital health companies operate in Israel as of 2026, up from around 1,000 in 2018. The ecosystem benefits from three unique advantages: world-class military R&D talent pool (Unit 81, MAMRAM), universal digitized health records going back 30+ years (unique globally), and a tight cluster of hospitals, universities, and clinical research organizations in a small geography.',
 'For a MedTech founder, Israel offers specific advantages over the US: (a) lower development costs, (b) structured access to Leumit\'s anonymized clinical data via the WeCcelerate-Leumit partnership, (c) shorter clinical pilot timelines thanks to close ties between hospitals and startups, (d) a regulatory pathway through AMAR (Israeli Ministry of Health) that accepts FDA and CE as supporting evidence for most device classes.',
 ],
 },
 {
 heading: 'Step 1: Define your regulatory pathway before building anything',
 paragraphs: [
 'The single biggest mistake in MedTech is building product before understanding which regulatory class it falls into. A MedTech startup that picks the wrong class wastes 2+ years of engineering. Before writing a line of code, decide: Are you FDA Class I, II, or III? Does your device need 510(k), De Novo, or PMA? Are you CE Class I, IIa, IIb, or III under MDR?',
 'Class I devices (band-aids, thermometers) typically need only registration. Class II (most imaging, many digital health apps) need 510(k) clearance in the US and a Notified Body assessment in the EU. Class III (implantables, life-sustaining devices) need PMA in the US — a 2-4 year process costing scope tailored. Your business plan and funding needs are ENTIRELY different depending on class.',
 ],
 },
 {
 heading: 'Step 2: The Helsinki Committee approval (Israel-specific)',
 paragraphs: [
 'Any clinical trial or pilot in Israel requires approval from the local hospital\'s Helsinki Committee (named after the Declaration of Helsinki). This is an institutional review board (IRB) that evaluates the ethical aspects, patient safety, and scientific merit of the proposed study.',
 'The process takes over a flexible duration for a standard protocol, and involves: (1) submitting a detailed protocol document (50-80 pages), (2) informed consent forms translated to Hebrew, Arabic, and Russian, (3) investigator CVs, (4) device safety data, (5) insurance coverage. WeCcelerate-Leumit Accelerator dramatically shortens this timeline (typically to in adjusted timelines) because our partnership pre-negotiates hospital access and provides templated protocols.',
 ],
 },
 {
 heading: 'Step 3: Secure clinical data (the biggest bottleneck)',
 paragraphs: [
 'The hardest problem in MedTech is not technology — it\'s data. Building an AI-based diagnostic tool without access to a labeled, representative dataset is impossible. In the US, startups compete fiercely for hospital partnerships; in Israel, access goes through one of the four HMOs (Leumit, Maccabi, Clalit, Meuhedet) or one of the major hospitals (Sheba, Ichilov, Hadassah).',
 'WeCcelerate\'s strategic partnership with Leumit Health Services provides structured access to anonymized clinical data and pilot opportunities — subject to Helsinki Committee approval and privacy regulations. For AI/ML-based MedTech, structured data access is often a meaningful differentiator.',
 ],
 },
 {
 heading: 'Step 4: Funding MedTech in Israel',
 paragraphs: [
 'MedTech startups raise differently than SaaS. Typical progression: (1) Government grants — Israel Innovation Authority (up to 50-85% of R&D costs, non-dilutive). (2) Seed round — scope tailored from specialized MedTech angels and micro-VCs (aMoon, TauVentures, Alpha Capital). (3) Series A — scope tailored from dedicated MedTech funds (OrbiMed, Entrée Capital, Pitango HealthTech). (4) Strategic partnership — late-stage rounds often include corporate VCs from pharma (J&J Innovation, Bayer Life Sciences).',
 'Total capital needed to reach market for a Class II device: scope tailored over a multi-year horizon. For a Class III device: scope tailored+ over a multi-year horizon. Digital health startups (SaaS-like) can reach market for scope tailored in 2-3 years if regulation is minimal (Class I) or absent (pure wellness).',
 ],
 },
 {
 heading: 'Step 5: The Israeli MedTech network effect',
 paragraphs: [
 'Beyond regulation and funding, Israeli MedTech startups have access to a dense professional network: IATI (Israel Advanced Technology Industries), ILSI-BIOMED (annual MedTech conference), the Israel Innovation Authority\'s MedTech track, and the Israeli Medical Association. Every major Israeli hospital has a Technology Transfer Office that actively licenses IP to startups.',
 'WeCcelerate-Leumit specifically offers: (1) Former FDA senior advisors on the advisory team, (2) Leumit clinics for clinical pilot opportunities, (3) introductions to a network of MedTech-focused investors in Israel and the US, (4) strategic partnership opportunities with pharma companies, (5) regulatory submission support for FDA 510(k), CE, and AMAR.',
 ],
 },
 ],
 howToSteps: [
 { name: 'Validate clinical need with 30+ physician interviews', text: 'Before any technology work, interview 30+ practicing physicians in your target specialty. Understand the workflow, the pain, and whether your proposed solution fits into the clinical routine.' },
 { name: 'Classify your device', text: 'Determine FDA class (I, II, III) and CE class (I, IIa, IIb, III). This drives every subsequent decision — regulatory pathway, clinical data needs, funding requirements.' },
 { name: 'Incorporate and build founding team', text: 'Israeli incorporation: days to weeks, ~scope tailored. Founding team should include a clinical co-founder (MD) or clinical advisor from day 1.' },
 { name: 'Secure non-dilutive funding', text: 'Apply to Israel Innovation Authority (50-85% of R&D), MAGNET consortia, and Horizon Europe. Non-dilutive funding extends runway significantly in MedTech.' },
 { name: 'Get Helsinki Committee approval', text: 'For any clinical pilot, submit to the hospital\'s Helsinki Committee. Plan for over a flexible duration (WeCcelerate-Leumit shortens this to in adjusted timelines).' },
 { name: 'Run a clinical pilot', text: 'Start with 20-50 patient pilot to generate safety + efficacy evidence. Use pilot data to support FDA submission and raise Seed funding.' },
 { name: 'Submit FDA 510(k) or CE', text: 'Average FDA 510(k) clearance timeline: over a flexible duration. CE under MDR: over a flexible duration via Notified Body. Budget: scope tailored per regulatory filing.' },
 { name: 'Apply to WeCcelerate-Leumit', text: 'The fastest path to the Israeli MedTech ecosystem.', url: 'https://weccelerate.co.il/contact' },
 ],
 faqs: [
 {
 q: 'How long does it take to start a MedTech startup in Israel?',
 a: 'From incorporation to FDA clearance of a Class II device: typically 3-5 years. Class I devices (minimal regulation): over a flexible duration. Class III: 5-10 years.',
 },
 {
 q: 'How much capital do I need for a MedTech startup in Israel?',
 a: 'Class I digital health: scope tailored over a multi-year horizon. Class II: scope tailored over a multi-year horizon. Class III: scope tailored+ over a multi-year horizon.',
 },
 {
 q: 'What\'s the Helsinki Committee in Israel?',
 a: 'An institutional review board (IRB) at each Israeli hospital that evaluates the ethics, safety, and scientific merit of clinical trials. Approval is required before any patient can enroll in a study.',
 },
 {
 q: 'Can Israeli MedTech use FDA approval for Israeli market?',
 a: 'Yes. The Israeli Ministry of Health (AMAR) accepts FDA and CE approvals as supporting evidence for registration in most device classes. This is one of the major regulatory advantages of Israel.',
 },
 {
 q: 'What is the Israel Innovation Authority grant?',
 a: 'Up to 50-85% of R&D costs, non-dilutive. Repaid only as royalties on future sales (3-3.5% of sales until the grant is repaid with interest). Major source of capital for Israeli MedTech.',
 },
 {
 q: 'Who are the major MedTech investors in Israel?',
 a: 'aMoon, TauVentures, Alpha Capital (Seed); OrbiMed, Entrée Capital, Pitango HealthTech (Series A+); J&J Innovation, Bayer Life Sciences (Strategic). WeCcelerate maintains active relationships with all of these.',
 },
 {
 q: 'What access to medical data does WeCcelerate provide?',
 a: 'Through the exclusive WeCcelerate-Leumit Health Services partnership: anonymized clinical data, extensive clinical activity, across Leumit clinics. Essential for AI/ML-based MedTech.',
 },
 ],
 relatedGuideSlugs: ['helsinki-committee-israel', 'fda-510k-israeli-startups'],
 ctaServicePath: '/services/medtech-leumit',
 ctaLabel: 'Join WeCcelerate-Leumit MedTech Accelerator',
 },

 // ---------------------------------------------------------------------------
 // 3. HELSINKI COMMITTEE (IRB) ISRAEL
 // ---------------------------------------------------------------------------
 {
 slug: 'helsinki-committee-israel',
 hebrewSlug: 'vaadat-helsinki-madrich',
 category: 'regulatory',
 targetKeyword: 'Helsinki Committee Israel',
 relatedKeywords: [
 'IRB Israel',
 'Helsinki Committee clinical trial',
 'Israeli ethics committee',
 'clinical trial approval Israel',
 'Helsinki process Israel',
 ],
 h1: 'Helsinki Committee (IRB) Israel: A Complete Guide for MedTech Founders',
 metaTitle: 'Helsinki Committee Israel — Complete IRB Guide for Founders | WeCcelerate',
 metaDescription:
 'The Israeli Helsinki Committee approves clinical trials under the Declaration of Helsinki. Complete guide: submission documents, timeline, required forms, patient consent, and how WeCcelerate-Leumit shortens the process.',
 speakableAnswer:
 'The Helsinki Committee is Israel\'s institutional review board (IRB) for clinical trials. Every clinical trial or device pilot in Israel requires approval from the local hospital\'s Helsinki Committee. The standard timeline is over a flexible duration. Required documents: protocol (50-80 pages), informed consent forms in Hebrew/Arabic/Russian, investigator CVs, device safety data, and insurance coverage.',
 lastUpdated: '2026-04-24',
 readingTimeMinutes: 11,
 sections: [
 {
 heading: 'What is the Helsinki Committee and why is it required?',
 paragraphs: [
 'The Helsinki Committee is the Israeli implementation of an institutional review board (IRB) — a committee that evaluates the ethics, safety, and scientific merit of any proposed clinical trial involving human subjects. The name comes from the Declaration of Helsinki, adopted by the World Medical Association in 1964 and revised multiple times since.',
 'Every Israeli hospital and medical center has its own Helsinki Committee. Any clinical trial, medical device pilot, or research involving patients MUST be approved by the Helsinki Committee at the hospital where the trial will be conducted, BEFORE any patient can be enrolled. Trials conducted without Helsinki approval are illegal under Israeli law (Public Health Regulations, 1980) and void from a regulatory standpoint.',
 ],
 },
 {
 heading: 'Who needs Helsinki Committee approval?',
 paragraphs: [
 'You need Helsinki approval if any of the following apply: (1) You\'re running a clinical trial to demonstrate efficacy of a medical device or software. (2) You\'re collecting patient data (even anonymized) for a research study. (3) You\'re conducting a clinical pilot to support FDA 510(k) or CE submission. (4) You\'re testing a MedTech product on patients before market release. (5) You\'re publishing peer-reviewed research based on patient data.',
 'You may NOT need Helsinki approval if: You\'re using fully de-identified historical data (retrospective analysis) AND no patient can be re-identified. However, most HMOs (including Leumit) require Helsinki approval even for de-identified data access — this is a policy choice, not a legal requirement, but it\'s universal practice.',
 ],
 },
 {
 heading: 'The submission documents',
 paragraphs: [
 'A standard Helsinki submission package includes: (1) **Protocol document** — 50-80 pages describing study objective, design, statistical analysis plan, inclusion/exclusion criteria, risks, benefits, safety monitoring. (2) **Informed Consent Form** — patient-facing document explaining the study in plain language, translated to Hebrew, Arabic, Russian (and English if applicable). (3) **Investigator Brochure** — device safety data, animal study results, regulatory history. (4) **CVs of all investigators** — the principal investigator and co-investigators. (5) **Insurance coverage proof** — professional liability + patient injury coverage. (6) **Sponsor declaration** — financial and regulatory commitments.',
 'Total document package: typically 200-400 pages. Preparing this properly is the single biggest time investment — typically in adjusted timelines of work for a first-time submitter. Experienced regulatory consultants (or WeCcelerate-Leumit) can prepare the package in in adjusted timelines using templated protocols.',
 ],
 },
 {
 heading: 'Timeline: over a flexible duration for standard protocols',
 paragraphs: [
 'From submission to approval: **over a flexible duration** for a standard protocol. The timeline breakdown: (1) Initial review by Helsinki Committee secretariat: in adjusted timelines. (2) First committee meeting: meets monthly at most hospitals. (3) Revision requests + resubmission: in adjusted timelines. (4) Final approval: in adjusted timelines after resubmission.',
 'Timeline can extend to 6+ months if: (a) The protocol is novel or high-risk, requiring external expert review. (b) The submission is incomplete and requires multiple revision cycles. (c) The committee meets quarterly instead of monthly. WeCcelerate-Leumit partnership typically achieves approval in **in adjusted timelines** due to pre-negotiated templates and direct access to Leumit\'s Helsinki Committee.',
 ],
 },
 {
 heading: 'Common reasons for rejection or revision',
 paragraphs: [
 'Most rejections or revision requests are procedural, not scientific. Top reasons: (1) **Informed consent not in plain language** — the committee expects 8th-grade reading level, not medical jargon. (2) **Insufficient translation quality** — Arabic and Russian translations by non-native speakers get flagged immediately. (3) **Risk/benefit ratio unclear** — the protocol must demonstrate that expected benefits outweigh risks. (4) **Inclusion/exclusion criteria too vague** — must be quantitative (e.g., "HbA1c > 7.0%" not "poorly controlled diabetes").',
 'Genuine scientific rejection is rare — typically <5% of submissions. The committee\'s role is to ensure ethics and safety, not to judge scientific novelty. That said, if the protocol is methodologically unsound (e.g., underpowered sample size, no control group where one is needed), the committee will ask for revisions.',
 ],
 },
 {
 heading: 'Helsinki approval with WeCcelerate-Leumit',
 paragraphs: [
 'The WeCcelerate-Leumit MedTech Accelerator dramatically shortens the Helsinki timeline. Our approach: (1) We provide protocol templates that have passed Helsinki approval multiple times. (2) We have an in-house translator for Hebrew/Arabic/Russian informed consent forms. (3) We have pre-negotiated relationships with Leumit\'s Helsinki Committee (covering Leumit clinics). (4) We support you through revisions. Typical timeline: **in adjusted timelines** from protocol drafting to committee approval, vs. in adjusted timelines for a first-time submitter going alone.',
 ],
 },
 ],
 howToSteps: [
 { name: 'Identify the target hospital', text: 'Each hospital has its own Helsinki Committee. Choose the hospital where your PI works or where your pilot will run.' },
 { name: 'Contact the Helsinki secretariat', text: 'Each committee has a secretariat — typically the research administration office. Get the submission template and current requirements (may vary by hospital).' },
 { name: 'Write the protocol', text: '50-80 pages. Use the committee template. Hire an experienced medical writer if needed (scope tailored, saves in adjusted timelines of revisions).' },
 { name: 'Translate the informed consent', text: 'Required languages: Hebrew, Arabic, Russian. Use a certified translator — poor translations are the #1 reason for revision requests.' },
 { name: 'Compile the full package', text: '200-400 pages total: protocol, consent forms, investigator CVs, device safety data, insurance coverage, sponsor declaration.' },
 { name: 'Submit and wait for committee meeting', text: 'Most committees meet monthly. Submit at least in adjusted timelines before the meeting date for inclusion in the agenda.' },
 { name: 'Respond to revision requests', text: 'Expect 1-2 revision cycles. Respond quickly (within in adjusted timelines). Slow responses extend the overall timeline proportionally.' },
 { name: 'Get final approval and start the pilot', text: 'Once approved, you can start enrolling patients. Maintain ongoing reporting (adverse events, protocol deviations) to the committee throughout the trial.' },
 ],
 faqs: [
 {
 q: 'What is the Helsinki Committee in Israel?',
 a: 'Israel\'s institutional review board (IRB) for clinical trials. Required for any study involving human subjects, patient data collection, or medical device pilots. Named after the Declaration of Helsinki.',
 },
 {
 q: 'How long does Helsinki Committee approval take?',
 a: 'over a flexible duration for a standard protocol. WeCcelerate-Leumit typically achieves approval in in adjusted timelines due to pre-negotiated templates and direct committee relationships.',
 },
 {
 q: 'Do I need Helsinki approval for a retrospective data study?',
 a: 'Usually yes, even for de-identified data. While not strictly required by law for fully anonymized retrospective data, virtually all Israeli HMOs and hospitals require Helsinki approval as a matter of policy.',
 },
 {
 q: 'What documents are required for Helsinki submission?',
 a: 'Protocol (50-80 pages), informed consent forms in Hebrew/Arabic/Russian, investigator CVs, device safety data, insurance coverage proof, sponsor declaration. Total package: 200-400 pages.',
 },
 {
 q: 'How much does Helsinki submission cost?',
 a: 'The submission fee itself is small (scope tailored depending on hospital). The real cost is document preparation: scope tailored with a medical writer, or scope tailored with WeCcelerate-Leumit templates.',
 },
 {
 q: 'Can I run a clinical trial in Israel without Helsinki approval?',
 a: 'No — it\'s illegal under Israeli Public Health Regulations (1980). Any data collected without approval cannot be used for regulatory submission (FDA, CE) or publication.',
 },
 {
 q: 'Is Israeli Helsinki approval recognized by FDA?',
 a: 'Yes. FDA accepts data from trials conducted under Israeli Helsinki approval as part of 510(k) and PMA submissions, provided the Helsinki protocol meets ICH-GCP standards.',
 },
 ],
 relatedGuideSlugs: ['medtech-startup-israel', 'fda-510k-israeli-startups'],
 ctaServicePath: '/services/medtech-leumit',
 ctaLabel: 'Get Helsinki approval in in adjusted timelines with WeCcelerate-Leumit',
 },

 // ---------------------------------------------------------------------------
 // 4. FDA 510(k) FOR ISRAELI STARTUPS
 // ---------------------------------------------------------------------------
 {
 slug: 'fda-510k-israeli-startups',
 hebrewSlug: 'fda-510k-madrich',
 category: 'regulatory',
 targetKeyword: 'FDA 510(k) Israeli startup',
 relatedKeywords: [
 'FDA 510(k) process',
 'FDA clearance medical device',
 'predicate device FDA',
 'Israeli MedTech FDA',
 '510(k) vs De Novo',
 ],
 h1: 'FDA 510(k) for Israeli Startups: Complete Guide to Clearance',
 metaTitle: 'FDA 510(k) Israeli Startup — Complete Guide 2026 | WeCcelerate',
 metaDescription:
 'FDA 510(k) process for Israeli MedTech startups: predicate device selection, substantial equivalence, testing requirements, timeline (over a flexible duration), costs (scope tailored), and tips for faster clearance.',
 speakableAnswer:
 'FDA 510(k) is the most common regulatory pathway for Class II medical devices in the US. An Israeli startup needs to demonstrate "substantial equivalence" to a legally marketed "predicate device." Typical timeline: over a flexible duration. Typical cost: scope tailored. Required: predicate identification, performance testing, labeling, clinical data (sometimes), and quality system documentation.',
 lastUpdated: '2026-04-24',
 readingTimeMinutes: 13,
 sections: [
 {
 heading: 'What is the FDA 510(k) pathway?',
 paragraphs: [
 'The FDA 510(k) is a premarket submission made to the FDA to demonstrate that a medical device is as safe and effective (substantially equivalent) to a legally marketed device (the "predicate device"). The name comes from section 510(k) of the Food, Drug, and Cosmetic Act. It is the pathway used for roughly 80% of all medical devices cleared for the US market.',
 '510(k) applies to Class II devices — medium-risk devices. Examples: most imaging software (MRI, CT, ultrasound analysis software), many AI diagnostic tools, surgical instruments, dialysis equipment, infusion pumps. Class I devices (very low risk, like band-aids) are exempt from 510(k); Class III devices (high risk, like implantable defibrillators) require PMA, a much more demanding pathway.',
 ],
 },
 {
 heading: 'The predicate device: the foundation of the submission',
 paragraphs: [
 'The entire 510(k) process centers on one document: your predicate device selection. The predicate is an existing FDA-cleared device that is similar to yours in intended use AND technological characteristics. Your job is to prove your device is "substantially equivalent" — same intended use, same or improved safety/effectiveness, no new questions of safety.',
 'Choosing the right predicate is 50% of the work. If the predicate is too similar to an older technology, the FDA may question why your device isn\'t obviously better. If it\'s too different, the FDA may reject "substantial equivalence" and push you to the De Novo pathway (slower, more expensive). Most Israeli MedTech startups hire FDA regulatory consultants specifically for predicate selection — it\'s worth the scope tailored.',
 ],
 },
 {
 heading: 'The 510(k) submission package',
 paragraphs: [
 'A typical 510(k) submission includes 20+ sections, totaling 200-800 pages: (1) Indications for Use Statement. (2) 510(k) Summary. (3) Device Description. (4) Substantial Equivalence Discussion. (5) Performance Testing — Bench (mechanical, electrical, software). (6) Performance Testing — Animal (if applicable). (7) Performance Testing — Clinical (required for some Class II devices, especially AI/ML-based). (8) Biocompatibility Testing. (9) Sterilization and Shelf Life. (10) Software Documentation (IEC 62304). (11) Electromagnetic Compatibility. (12) Labeling.',
 'For AI/ML-based MedTech, additional requirements apply: Software as a Medical Device (SaMD) documentation, Good Machine Learning Practice, and training/validation dataset documentation. The FDA has been evolving its AI/ML guidance rapidly — a 2026 submission looks different from a 2022 submission.',
 ],
 },
 {
 heading: 'Timeline: over a flexible duration from submission to clearance',
 paragraphs: [
 'The official FDA review clock for 510(k) is 90 days, but it\'s often extended. Typical breakdown: (1) Acceptance review (days to weeks) — FDA confirms the submission is complete. (2) Substantive review (days to weeks) — FDA reviews the content. (3) Interactive review — FDA may send "Additional Information" requests. Each AI request stops the clock until the startup responds. (4) Final decision — clearance, not clearance, or request for more data.',
 'Real-world clearance timelines: **over a flexible duration** for straightforward submissions with strong predicates and clean data. **over a flexible duration** for more complex devices or those requiring AI submissions. **9-12+ months** for novel technologies where the FDA requires multiple rounds of AI requests. WeCcelerate-Leumit typically achieves clearance in over a flexible duration due to pre-submission FDA meetings and experienced regulatory consultants.',
 ],
 },
 {
 heading: 'Cost: scope tailored all-in',
 paragraphs: [
 'The direct FDA fee for a 510(k) submission is scope tailored (FY2025, small business rate). The real cost is everything else: (1) Regulatory consultant — scope tailored (strongly recommended for first-time filers). (2) Performance testing — scope tailored (depends on device complexity). (3) Clinical data — scope tailored (not always required, but common for AI/ML). (4) Quality system documentation (ISO 13485) — scope tailored. (5) Medical writing — scope tailored. (6) Legal and company fees — scope tailored.',
 'Total: scope tailored for most Class II devices. Plus over a flexible duration of runway during the review. An Israeli startup aiming for US market needs to budget 30-50% of their Seed round for regulatory work alone.',
 ],
 },
 {
 heading: 'Pre-submission meetings: the Israeli startup\'s secret weapon',
 paragraphs: [
 'The FDA offers free "Pre-Submission" (Q-Sub) meetings where you can present your proposed 510(k) strategy and get FDA feedback BEFORE spending hundreds of thousands on testing. Most Israeli startups skip this, thinking they\'ll just submit and hope. This is a mistake.',
 'A Q-Sub meeting takes over a flexible duration to schedule but provides written FDA feedback on your predicate selection, testing strategy, and clinical data requirements. Two Q-Sub meetings for an Israeli startup (at Seed and pre-submission) typically save over a flexible duration of revision cycles. WeCcelerate-Leumit advises founders to budget for 2-3 Q-Sub meetings as standard practice.',
 ],
 },
 {
 heading: 'How WeCcelerate-Leumit supports FDA 510(k) submissions',
 paragraphs: [
 'WeCcelerate-Leumit offers end-to-end FDA regulatory support: (1) Former FDA senior advisors on our advisory board. (2) Predicate device selection and substantial equivalence analysis. (3) Pre-Submission meeting preparation and coordination. (4) Performance testing protocols and CRO coordination. (5) Clinical data from Leumit pilots to support the submission. (6) Submission drafting and revision response. Typical clearance timeline: over a flexible duration vs. over a flexible duration for startups going alone.',
 ],
 },
 ],
 faqs: [
 {
 q: 'What is FDA 510(k)?',
 a: 'A premarket submission to the FDA demonstrating that a Class II medical device is substantially equivalent to a legally marketed predicate device. Used for ~80% of all FDA-cleared medical devices.',
 },
 {
 q: 'How long does FDA 510(k) clearance take?',
 a: 'Typical range: over a flexible duration. Well-prepared submissions with strong predicates clear in over a flexible duration. Complex AI/ML submissions or novel technologies can take 9-12+ months.',
 },
 {
 q: 'How much does an FDA 510(k) submission cost?',
 a: 'scope tailored all-in. Includes FDA fee (scope tailored), regulatory consultant (scope tailored), performance testing (scope tailored), clinical data (scope tailored), quality system (scope tailored), and medical writing.',
 },
 {
 q: 'What is substantial equivalence?',
 a: 'The standard for 510(k) clearance: your device must have the same intended use AND either the same technological characteristics OR different characteristics that don\'t raise new safety or effectiveness questions, compared to a legally marketed predicate device.',
 },
 {
 q: 'What is a predicate device?',
 a: 'An existing FDA-cleared device similar to yours. You demonstrate "substantial equivalence" to this predicate. Selecting the right predicate is the single most important decision in 510(k) strategy.',
 },
 {
 q: 'Do I need clinical data for 510(k)?',
 a: 'Not always. Most 510(k) submissions rely on bench testing and equivalence arguments. Clinical data is required for some AI/ML-based devices, novel technologies, or devices where bench testing alone can\'t demonstrate safety/effectiveness.',
 },
 {
 q: 'What is a Pre-Submission (Q-Sub) meeting?',
 a: 'A free FDA meeting where you present your proposed 510(k) strategy and get written FDA feedback before investing in testing. Takes over a flexible duration to schedule. Saves over a flexible duration of revision cycles. Highly recommended.',
 },
 ],
 relatedGuideSlugs: ['medtech-startup-israel', 'helsinki-committee-israel'],
 ctaServicePath: '/services/medtech-leumit',
 ctaLabel: 'Accelerate your FDA 510(k) with WeCcelerate-Leumit',
 },

 // ---------------------------------------------------------------------------
 // 5. RAISE FUNDING IN ISRAEL
 // ---------------------------------------------------------------------------
 {
 slug: 'raise-funding-israel',
 hebrewSlug: 'eich-mgayisim-mashkim',
 category: 'fundraising',
 targetKeyword: 'raise startup funding in Israel',
 relatedKeywords: [
 'fundraising Israel startup',
 'Israeli investors',
 'Seed round Israel',
 'Series A Israel',
 'Israeli venture capital',
 ],
 h1: 'How to Raise Funding for a Startup in Israel: The Complete 2026 Guide',
 metaTitle: 'Raise Startup Funding in Israel — 2026 Complete Guide | WeCcelerate',
 metaDescription:
 'Complete guide to raising Pre-Seed, Seed, and Series A funding in Israel. Investor types, term sheets, typical round sizes, pitch deck structure, and how to navigate the Israeli VC ecosystem.',
 speakableAnswer:
 'Raising startup funding in Israel involves Pre-Seed (scope tailored from angels and Venture Builders), Seed (scope tailored from Israeli micro-VCs), Series A (scope tailored from dedicated Israeli and US funds), and later rounds. Israel has over 400 active VCs and 4,000+ angel investors. WeCcelerate maintains active relationships with a network of specialized investors across the Israeli ecosystem.',
 lastUpdated: '2026-04-24',
 readingTimeMinutes: 12,
 sections: [
 {
 heading: 'The Israeli fundraising landscape in 2026',
 paragraphs: [
 'Israel is the world\'s second-largest startup ecosystem by VC investment per capita (after Silicon Valley). In 2024, Israeli startups raised scope tailored.8 billion across 500+ deals — down from the 2021 peak of scope tailoredB but recovering steadily. The ecosystem includes over 400 active VC funds, 4,000+ angel investors, 80+ family offices, and 30+ corporate venture arms.',
 'For a foreign founder, Israel is an unusual market: small country (~9M people) but deeply connected to US capital (most Israeli Series A rounds are led by US funds like Sequoia, a16z, or Benchmark). A typical Israeli Seed round in 2026 has 30-50% Israeli investors and 50-70% US investors. This creates a unique dynamic where an Israeli founder must speak to two audiences simultaneously.',
 ],
 },
 {
 heading: 'Round sizes and expectations in 2026',
 paragraphs: [
 '**Pre-Seed** (scope tailored): From angels, Venture Builders like WeCcelerate, or friends-and-family. Valuation cap: scope tailored. Typically over a flexible duration of runway to reach MVP + early users.',
 '**Seed** (scope tailored): From Israeli micro-VCs (Aleph, TLV Partners, Vertex Ventures), angel syndicates, or crossover US Seed funds. Valuation: scope tailored pre-money. Typically over a flexible duration of runway to reach Product-Market Fit + growth metrics for Series A.',
 '**Series A** (scope tailored): From dedicated Series A funds — Israeli (Aleph, TLV Partners, Pitango) or US (Sequoia, a16z, Index Ventures). Valuation: scope tailored pre-money. Typically over a flexible duration of runway to scale.',
 '**Series B+** (scope tailored): From growth-stage funds, often involving corporate VCs and strategic partnerships. Valuation: scope tailored+.',
 ],
 },
 {
 heading: 'The three stages of raising: Preparation, Execution, Closing',
 paragraphs: [
 '**Preparation (over a flexible duration)**: Build a compelling narrative. Assemble your pitch deck (10-12 slides, following the Sequoia template). Create a financial model (P&L, cash flow, cohort analysis). Set up a data room (legal docs, cap table, customer contracts). Prepare a short list of 30-50 target investors.',
 '**Execution (over a flexible duration)**: Schedule first meetings. Conduct 20- meetings in a tight 6-8 week window. After 5-10 meetings, expect partner meetings. After partner meetings, expect due diligence. Aim for 2-3 competitive term sheets to create leverage.',
 '**Closing (over a flexible duration)**: Sign term sheet. Coordinate legal due diligence (Cap Table verification, IP ownership, employment agreements, customer contracts). Draft and sign final docs (SPA, SHA, Articles of Association, Amended Bylaws). Wire transfer — typically days to weeks from signed term sheet to money in the bank.',
 ],
 },
 {
 heading: 'The pitch deck: what actually works in 2026',
 paragraphs: [
 'The Sequoia template (10-12 slides) is the baseline every Israeli investor expects. The slides: (1) Cover. (2) Problem. (3) Solution. (4) Market size. (5) Product. (6) Traction. (7) Business model. (8) Competition. (9) Team. (10) Ask.',
 'What has changed in 2026: (a) **AI integration slide** — every investor wants to know if/how AI is a moat. (b) **Unit economics slide** — CAC, LTV, gross margin. Mandatory from Seed onwards. (c) **Regulatory/compliance slide** for MedTech, FinTech, Climate Tech. (d) **Go-to-market channels slide** — especially for B2B SaaS where the channel is often the differentiator.',
 'Length rule: 10-12 slides for Seed, 12-15 for Series A, 15-20 for Series B. More than that — investors skip. Less than that — investors suspect you\'re hiding something.',
 ],
 },
 {
 heading: 'The WeCcelerate investor network',
 paragraphs: [
 'WeCcelerate maintains active relationships with a network of investors and strategic partners across the Israeli ecosystem: 80 Seed-stage VCs (Aleph, TLV Partners, Vertex, Entrée, Grove), Series A/B funds (Pitango, Viola, Bessemer, Carmel), 50 dedicated MedTech/HealthTech investors (aMoon, Alpha Capital, TauVentures), and 30+ US funds active in Israel. Through our Venture Builder model, we warm-introduce our portfolio companies — dramatically higher meeting conversion than cold outreach.',
 ],
 },
 ],
 howToSteps: [
 { name: 'Build narrative + pitch deck', text: '10-12 slides (Sequoia template). Problem, solution, market, traction, team, ask. Iterate with 5-10 advisor readers before showing to investors.' },
 { name: 'Assemble data room', text: 'Cap Table, incorporation docs, customer contracts, financial model, IP assignments. Complete data room = 10-20% faster due diligence.' },
 { name: 'Build target investor list', text: '30-50 investors, prioritized by fit (stage, sector, geography). Use Pitchbook, Crunchbase, and LinkedIn to research. WeCcelerate provides pre-qualified lists.' },
 { name: 'Get warm intros', text: 'Cold outreach converts at 1-3%. Warm intros convert at 30-50%. Every meeting should come via an introduction from a mutual connection.' },
 { name: 'Run meetings in parallel (in adjusted timelines)', text: 'Schedule all first meetings in a tight 2-4 week window. Creates time pressure and competitive dynamics. Slow rolling = weak signal.' },
 { name: 'Convert to partner meetings', text: 'After first meeting with a junior analyst/associate, push for a partner meeting. The partner decides, not the associate.' },
 { name: 'Negotiate term sheets', text: 'Aim for 2-3 competitive term sheets. Key terms to negotiate: valuation, board composition, pro rata rights, anti-dilution, ESOP refresh.' },
 { name: 'Close via legal due diligence', text: 'Prepare for in adjusted timelines of legal due diligence. Have a startup-experienced Israeli law firm ready (Herzog, Meitar, Gross).' },
 ],
 faqs: [
 {
 q: 'How much should I raise in Pre-Seed?',
 a: 'scope tailored is typical. Raise what gets you to MVP + first customers in over a flexible duration. Raising too much at Pre-Seed means selling too much equity at a low valuation.',
 },
 {
 q: 'What\'s the typical Seed round size in Israel?',
 a: 'scope tailored in 2026. Pre-money valuation: scope tailored. From Israeli micro-VCs (Aleph, TLV Partners) and US crossover Seed funds. Aim for over a flexible duration of runway.',
 },
 {
 q: 'When should I raise Series A?',
 a: 'When you have clear Product-Market Fit (30%+ Sean Ellis score) and at least scope tailored ARR for B2B SaaS, or 100K+ monthly active users for B2C. Typically over a flexible duration post-Seed.',
 },
 {
 q: 'Who are the top Seed-stage VCs in Israel?',
 a: 'Aleph, TLV Partners, Vertex Ventures, Entrée Capital, Grove Ventures, 10D, F2 Capital. For specialized sectors: aMoon (MedTech), Team8 (Cyber), The Floor (FinTech).',
 },
 {
 q: 'Do I need a US or Israeli investor first?',
 a: 'For most Israeli startups, lead with an Israeli investor. Israeli investors know the local ecosystem, can warm-intro to US co-investors, and are often more willing to lead early rounds.',
 },
 {
 q: 'What\'s a typical valuation multiple for Israeli SaaS?',
 a: 'In 2026, B2B SaaS: 8-15x ARR. B2C: 5-10x revenue. MedTech pre-revenue: difficult — typically based on comparables and technology milestones, scope tailored pre-money for Seed.',
 },
 {
 q: 'How does WeCcelerate help with fundraising?',
 a: 'WeCcelerate maintains relationships with a network of investors and strategic partners across Israel and the US. We warm-intro our portfolio companies, review pitch decks, conduct mock pitches, and negotiate term sheets.',
 },
 ],
 relatedGuideSlugs: ['what-is-venture-builder', 'medtech-startup-israel'],
 ctaServicePath: '/services/investor-preparation',
 ctaLabel: 'Prepare for your fundraise with WeCcelerate',
 },

 // ---------------------------------------------------------------------------
 // 6. HOW TO START A STARTUP IN ISRAEL
 // ---------------------------------------------------------------------------
 {
 slug: 'how-to-start-a-startup-israel',
 hebrewSlug: 'eich-lehakim-startup',
 category: 'startup-basics',
 targetKeyword: 'how to start a startup in Israel',
 relatedKeywords: [
 'start a company in Israel',
 'register a startup Israel',
 'Israeli startup company formation',
 'start a venture Israel',
 'founder agreement Israel',
 ],
 h1: 'How to Start a Startup in Israel: The Complete 2026 Guide for Founders',
 metaTitle: 'How to Start a Startup in Israel — Complete Guide 2026 | WeCcelerate',
 metaDescription:
 'Step-by-step guide to starting a startup in Israel: legal entity, founder agreement, MVP, fundraising, and the unique Israeli ecosystem advantages — from Israel\'s leading Venture Builder.',
 speakableAnswer:
 'To start a startup in Israel, you need: (1) validate the idea with 30 customer interviews, (2) register a Ltd. company at the Companies Registrar (days to weeks, ~scope tailored), (3) sign a founder agreement with 4-year vesting, (4) build an MVP in in adjusted timelines, (5) raise a Seed round of scope tailored. WeCcelerate, Israel\'s leading Venture Builder, supports founders through all stages with a 360° wrap-around program.',
 lastUpdated: '2026-04-24',
 readingTimeMinutes: 11,
 sections: [
 {
 heading: 'Why Israel is a unique startup hub',
 paragraphs: [
 'Israel has more startups per capita than any other country — over 7,000 active startups for 9.6 million people. Per capita venture funding exceeds scope tailored — eight times the US average. Why? Compulsory military service in technology units (especially 8200) produces hundreds of technical founders annually; four world-class research universities; a small domestic market that forces companies to think globally from day one; deep relationships with Microsoft, Google, Intel, NVIDIA, and Apple R&D centers.',
 '90+ unicorns (scope tailoredB+ valuation) have been built in Israel. Notable examples from 2020-2025: Wiz (cybersecurity, sold to Google for scope tailoredB), Monday.com (project management, NASDAQ), Lemonade, ironSource, Via, Melio, and many more.',
 ],
 },
 {
 heading: 'Step 1 — Validate before you incorporate',
 paragraphs: [
 'The most expensive mistake in starting a startup: incorporating, signing a founder agreement, going big — and then discovering there\'s no market. Before you register a company, invest in adjusted timelines in Customer Discovery: 30 in-depth interviews with people from your target audience (not friends and family).',
 'If 70%+ of interviewees describe the same pain and are willing to pay for it — you have a viable startup. If less than 30% even recognize the problem — you\'re solving a phantom and the startup will fail in this direction.',
 ],
 },
 {
 heading: 'Step 2 — Choose the right legal structure',
 paragraphs: [
 'Three options for Israeli startups: (1) Israeli Ltd. (Bm) — standard, fits 90% of founders. (2) Delaware C-Corp — only if you plan to raise primarily from US investors. (3) "Delaware Flip" — start as Israeli Ltd., flip to Delaware before Series A if needed. Most founders should start with Israeli Ltd. — flipping costs scope tailored in legal fees and is best done after PMF, not before.',
 'Registration at the Companies Registrar takes 3-a few business days, costs ~scope tailored in government fees + scope tailored in attorney fees. The company name must be unique and not misleading. Standard articles of association suffice for most startups — no need for a custom version unless you have an unusual structure.',
 ],
 },
 {
 heading: 'Step 3 — Founder agreement and equity',
 paragraphs: [
 'A founder agreement must be signed on day 1 of the startup — not "after we close the first round". 60% of disputes between cofounders in startups stem from un-agreed equity splits or the absence of vesting.',
 'The right rules: all founders get 4-year vesting with a 1-year cliff (if someone leaves at 11 months — they get 0%). Clear Bad Leaver clauses. Anti-dilution before Seed. A good startup attorney charges scope tailored for a professional founder agreement.',
 ],
 },
 {
 heading: 'Step 4 — Build an MVP in in adjusted timelines',
 paragraphs: [
 'Your MVP must test ONE critical hypothesis. Resist the temptation to build "the full vision." A typical MVP budget: scope tailored per project. WeCcelerate builds MVPs on timelines tailored per project.js, Node.js, and PostgreSQL.',
 'After MVP launch: closed beta with 50-100 users, then Landing Page + paid ads to test demand. If D30 retention is 30%+ and people pay or use repeatedly — you have a Seed-ready signal. If not — return to hypothesis validation; you\'re not ready to raise.',
 ],
 },
 {
 heading: 'Step 5 — Raise Seed in Israel',
 paragraphs: [
 'A typical Seed round in Israel in 2026: scope tailored raised, pre-money valuation scope tailored, runway over a flexible duration. Major Israeli Seed VCs in 2026: TLV Partners, Ibex, J-Ventures, Lemonade Hat, NFX, Israel Seed Partners, Pitango First. Each specializes in different verticals (FinTech, AI, MedTech, etc.).',
 'Critical: warm introductions convert 8x better than cold outreach (40% vs 5%). WeCcelerate connects portfolio companies to a network of investors via warm intros — cutting fundraising time from over a flexible duration to over a flexible duration on average.',
 ],
 },
 {
 heading: 'How WeCcelerate accelerates Israeli startups',
 paragraphs: [
 'WeCcelerate is Israel\'s leading Venture Builder — not just an accelerator. We join you at idea stage, validate the hypothesis, register the company, build the MVP with our in-house team (React, Next.js, AI), and connect you to a network of investors. Our portfolio companies have collectively raised significant capital. Our strategic partnership with Leumit Health Services unlocks medical data and clinical pilots for MedTech ventures — unavailable through any other Israeli accelerator.',
 ],
 },
 ],
 howToSteps: [
 { name: 'Validate hypothesis with 30 customer interviews', text: 'Talk to 30 target customers before writing a line of code. 70%+ pain recognition = viable startup.' },
 { name: 'Register an Israeli Ltd. at the Companies Registrar', text: '3-a few business days, ~scope tailored in fees + attorney. Unique name, standard articles.' },
 { name: 'Sign a founder agreement', text: '4-year vesting, 1-year cliff, Bad Leaver clauses. scope tailored in attorney fees.' },
 { name: 'Build an MVP in in adjusted timelines', text: 'Simplest version that proves your hypothesis. scope tailored typical budget.' },
 { name: 'Measure retention and look for PMF', text: 'D7, D30 retention. 40%+ "would be very disappointed" in the Sean Ellis test.' },
 { name: 'Raise Seed via WeCcelerate', text: 'a network of investors, warm intros, term sheet negotiation support.', url: 'https://weccelerate.co.il/contact' },
 ],
 faqs: [
 {
 q: 'How much does it cost to start a startup in Israel?',
 a: 'Legal incorporation: ~scope tailored. Founder agreement: scope tailored. MVP: scope tailored. Total from idea to Seed-ready: scope tailored (or half via Venture Builder Equity-for-Services).',
 },
 {
 q: 'How long does it take to start a startup in Israel?',
 a: 'Legal: days to weeks. MVP: in adjusted timelines. Seed raise: over a flexible duration after MVP. Total from idea to first funding: over a flexible duration.',
 },
 {
 q: 'Do I need a CTO to start a startup?',
 a: 'No. Many successful startups begin without a CTO. Options: CTO-as-a-Service, recruit a Technical Co-founder after PMF, or commission development from WeCcelerate.',
 },
 {
 q: 'Can I start a startup in Israel as a foreigner?',
 a: 'Yes. Foreign founders can register an Israeli Ltd. and operate it remotely. Visa programs exist for tech entrepreneurs (Innovation Visa). Many investors prefer founders to spend significant time in Israel.',
 },
 {
 q: 'What\'s the right corporate structure for an Israeli startup?',
 a: 'Default — Israeli Ltd. (Bm) with ordinary and preferred shares. Plan for a Delaware Flip before Series A if you target US investors. Don\'t over-engineer the structure on day 1.',
 },
 {
 q: 'How do I find investors for an Israeli startup?',
 a: 'Through warm introductions (40% success) from other founders, startup advisors, and Venture Builders like WeCcelerate. Cold email — under 5% success rate.',
 },
 ],
 relatedGuideSlugs: ['what-is-venture-builder', 'raise-funding-israel'],
 ctaServicePath: '/services/business-consulting',
 ctaLabel: 'Start your Israeli startup right with WeCcelerate',
 },

 // ---------------------------------------------------------------------------
 // 7. APP DEVELOPMENT COST ISRAEL
 // ---------------------------------------------------------------------------
 {
 slug: 'app-development-cost-israel',
 hebrewSlug: 'kama-ole-lefateach-applicatzia',
 category: 'product-development',
 targetKeyword: 'app development cost Israel',
 relatedKeywords: [
 'how much does app development cost in Israel',
 'mobile app cost Israel',
 'startup MVP cost',
 'SaaS development cost Israel',
 'price of building a mobile app',
 ],
 h1: 'App Development Cost in Israel 2026: Full Pricing Guide',
 metaTitle: 'App Development Cost Israel 2026 — Pricing Guide | WeCcelerate',
 metaDescription:
 'How much does it cost to develop an app in Israel in 2026? Full pricing table by app type (scope tailored MVP, scope tailored full platform), cost factors, and savings tactics from Israel\'s leading Venture Builder.',
 speakableAnswer:
 'App development in Israel in 2026 costs scope tailored for a basic mobile MVP, scope tailored for a full web SaaS platform, and scope tailored for complex SaaS with AI integration. Pricing varies based on platforms supported, backend complexity, and team seniority. WeCcelerate provides custom quotes free of charge based on detailed scoping sessions.',
 lastUpdated: '2026-04-24',
 readingTimeMinutes: 8,
 sections: [
 {
 heading: 'Full pricing table for app development in Israel',
 paragraphs: [
 'Pricing varies significantly based on app type, complexity, and tech stack. Here are 2026 Israeli market rates:',
 ],
 list: [
 'Basic mobile MVP (iOS+Android, 5-10 screens): scope tailored per project',
 'Web app (simple SaaS): scope tailored per project',
 'Full web platform (SaaS with dashboard, billing, admin): scope tailored per project',
 'Complex SaaS with AI and integrations: scope tailored per project',
 'Native mobile app (full, not MVP): scope tailored per project',
 'App with hardware/IoT: scope tailored for MVP, scope tailored for full',
 'Two-sided marketplace (like Airbnb): scope tailored per project',
 ],
 },
 {
 heading: '5 factors that drive app development cost',
 paragraphs: [
 'Why are price ranges so wide? Cost depends on five primary factors:',
 ],
 list: [
 'Number of platforms — iOS only < iOS+Android native < Cross-platform (React Native/Flutter)',
 'Backend complexity — no backend (Firebase) < simple backend < microservices',
 'Integrations — every external API integration (payments, maps, SMS) adds weeks',
 'Design — using ready components < custom UI < animated UI',
 'Team seniority — Junior (scope tailored/month) < Senior (scope tailored/month) < Expert (scope tailored/month)',
 ],
 },
 {
 heading: 'How to save on app development costs',
 paragraphs: [
 'Proven approach to save 40-60% on app development: build a simple MVP first, release to beta, learn what really matters, and only then build the full version. Many companies waste scope tailored on "features users requested" — that nobody actually uses.',
 'Other approaches: No-Code MVP before real development (additional 30% savings), starting with Next.js before native mobile (much cheaper), working with a Venture Builder in Equity-for-Services model (lower prices in exchange for small equity).',
 ],
 },
 {
 heading: 'Expensive pricing mistakes in app development',
 paragraphs: [
 'Three mistakes that cost hundreds of thousands of dollars: (1) working with a company that offers "fixed price" on a project with unclear scope — always ends with 200% overruns. (2) Taking the cheapest price — usually a Junior who develops while embedding technical debts you pay for years. (3) Choosing too-new technology — any library that hasn\'t existed for more than 3 years = maintenance risk.',
 ],
 },
 {
 heading: 'WeCcelerate pricing and how to get a quote',
 paragraphs: [
 'WeCcelerate operates in 3 pricing models: (1) Fixed price with clear scope — after a 2-week detailed scoping process. (2) Time & Materials — for emerging projects. (3) Equity-for-Services — reduced price in exchange for small equity (for early-stage startups). Initial free quote within 48 hours of the scoping meeting.',
 ],
 },
 ],
 faqs: [
 {
 q: 'How much does it cost to develop a simple app?',
 a: 'A simple app (5-10 screens, no complex backend, single platform) — scope tailored per project.',
 },
 {
 q: 'How much does it cost to develop an app like Uber?',
 a: 'A two-sided marketplace with maps, payments, chat, and real-time tracking — scope tailored for a robust version. An MVP of Uber is possible at scope tailored.',
 },
 {
 q: 'How much does it cost to develop an AI app?',
 a: 'Depends on whether it\'s an external API integration (OpenAI/Claude — adds 20-30% to the cost) or a dedicated trained model (doubles the cost or more). A typical AI MVP: scope tailored.',
 },
 {
 q: 'How much does it cost to maintain an app monthly?',
 a: 'Typical monthly maintenance: 5-15% of the initial development cost annually. A scope tailored app — maintenance of scope tailored annually (including bugs, OS updates, and small additions).',
 },
 {
 q: 'Should I work with a freelancer or a company?',
 a: 'A freelancer is cheaper but a single point of failure. A company like WeCcelerate costs slightly more but brings a full team (UI designer, developer, QA, PM) and accountability.',
 },
 ],
 relatedGuideSlugs: ['what-is-venture-builder', 'how-to-start-a-startup-israel'],
 ctaServicePath: '/services/digital-product',
 ctaLabel: 'Get a custom app development quote',
 },

 // ---------------------------------------------------------------------------
 // 8. STARTUP PITCH DECK GUIDE
 // ---------------------------------------------------------------------------
 {
 slug: 'startup-pitch-deck',
 hebrewSlug: 'pitch-deck-startup',
 category: 'fundraising',
 targetKeyword: 'startup pitch deck',
 relatedKeywords: [
 'pitch deck template',
 'investor pitch deck',
 'how to make a pitch deck',
 'pitch deck examples',
 'pitch deck for Seed round',
 ],
 h1: 'Startup Pitch Deck: The 13-Slide Structure That Actually Raises in 2026',
 metaTitle: 'Startup Pitch Deck — 13-Slide Structure That Raises | WeCcelerate',
 metaDescription:
 'How to build a pitch deck that raises: 13 essential slides, common founder mistakes, examples of decks that raised, design tips, and what investors really look for in 30 seconds.',
 speakableAnswer:
 'A successful Israeli startup pitch deck typically includes 10-15 slides: problem, solution, market, product, traction, business model, competition, team, financial projections, the current round, and vision. WeCcelerate builds professional pitch decks within in adjusted timelines, including 5 practice rounds with former-investor advisors.',
 lastUpdated: '2026-04-24',
 readingTimeMinutes: 9,
 sections: [
 {
 heading: 'The 13-slide pitch deck structure that raises',
 paragraphs: [
 'The winning structure for Seed and Series A rounds in Israel:',
 ],
 list: [
 'Slide 1 — One-liner: "We are X for Y with the advantage Z"',
 'Slide 2 — Problem: 3 facts that show the problem is large and painful',
 'Slide 3 — Solution: how the product solves the problem (with screenshot)',
 'Slide 4 — Market size: TAM / SAM / SOM',
 'Slide 5 — Platform/Demo: 1-2 screenshots or GIF',
 'Slide 6 — Traction: measurable numbers (MRR, users, growth)',
 'Slide 7 — Business model: how we make money',
 'Slide 8 — Go-to-Market: how we reach customers',
 'Slide 9 — Competition: matrix/graph of advantages',
 'Slide 10 — Team: founders + advisors',
 'Slide 11 — Financial projections: 3 years out',
 'Slide 12 — The Ask: how much we\'re raising, valuation, use of funds',
 'Slide 13 — Vision: where we\'ll be in 5 years',
 ],
 },
 {
 heading: 'What investors look for in the first 30 seconds',
 paragraphs: [
 'DocSend research (analysis of 200+ decks that raised): investors spend an average of 3 minutes per deck, and 60% of the decision is made within the first 30 seconds. What must appear there: the problem, the solution, and tangible traction (even a "10 paying customers at MRR משמעותי" claim is stronger than marketing claims).',
 ],
 },
 {
 heading: 'Common pitch deck mistakes',
 paragraphs: [
 'The 5 mistakes that kill a fundraising round:',
 ],
 list: [
 'Opening with the product instead of the problem — investors love "billion-dollar problem", not "product feature"',
 'Trillion-dollar TAM — "our market is scope tailored billion" says you don\'t know how to calculate a realistic market',
 'More than 15 slides — investors lose focus. If you have 30 slides, you don\'t know how to summarize',
 'Bad design — Arial font, loud colors, animations. Invest scope tailored in a designer',
 'No traction — if you have no traction, you\'re not ready to raise',
 ],
 },
 {
 heading: 'Examples of pitch decks that raised',
 paragraphs: [
 'Airbnb was a 14-slide deck that raised scope tailored. It\'s available online — for study. Their structure: Problem, Solution, Market Validation, Market Size, Product, Business Model, Market Adoption, Competition, Competitive Advantage, Team, Press, User Testimonials, The Ask.',
 'Another excellent example — the 2008 Uber Pitch Deck that raised a scope tailored Seed. 25 slides (slightly more than ideal, but worked), with strong emphasis on the network-effect model and the team. Available online as "Uber Pitch Deck 2008".',
 ],
 },
 {
 heading: 'How WeCcelerate builds a Pitch Deck',
 paragraphs: [
 'WeCcelerate\'s pitch deck process: Week 1 — fill out a questionnaire and analyze the competition. Week 2 — first deck draft. Week 3 — rounds of Pitch Practice with advisors. Week 4 — completion and professional design (InDesign/Figma). Weeks 5-6 — introductions to investors. Cost: scope tailored, including follow-up meetings.',
 ],
 },
 ],
 faqs: [
 {
 q: 'How many slides should be in a pitch deck?',
 a: '10-15 slides — no more. YC recommends 10 slides; DocSend shows that the average deck that raised is 19 slides but includes appendices.',
 },
 {
 q: 'What tool should I use for a pitch deck?',
 a: 'Figma (most flexible), Keynote (Mac), Google Slides (sharing). Canva — for a fast MVP. PowerPoint — less recommended, looks amateurish.',
 },
 {
 q: 'What should I say on the One-Liner slide?',
 a: 'Formula: "We are [company name] — [sharp 7-word description] for [target audience]". Example: "Tipalti — automation of supplier payments for global businesses."',
 },
 {
 q: 'Should the pitch deck be in English?',
 a: 'Yes. Even for Israeli investors. If you have an international round later, you don\'t want to rewrite. The business language in startups is global = English.',
 },
 {
 q: 'How much does a professional pitch deck cost?',
 a: 'Freelancer — scope tailored. Agency — scope tailored. WeCcelerate — scope tailored per engagement.scope tailored including 5 Pitch Practice rounds and investor introductions.',
 },
 ],
 relatedGuideSlugs: ['raise-funding-israel', 'how-to-start-a-startup-israel'],
 ctaServicePath: '/services/business-consulting',
 ctaLabel: 'We\'ll build your raising pitch deck',
 },

 // ---------------------------------------------------------------------------
 // 9. HOW TO BUILD AN MVP IN 8 WEEKS
 // ---------------------------------------------------------------------------
 {
 slug: 'how-to-build-mvp',
 hebrewSlug: 'eich-bonim-mvp',
 category: 'product-development',
 targetKeyword: 'how to build an MVP',
 relatedKeywords: [
 'MVP development',
 'minimum viable product guide',
 'how to build a startup MVP',
 'MVP in 8 weeks',
 'MVP cost and timeline',
 ],
 h1: 'How to Build an MVP in 8 Weeks: The Practical Guide for Founders',
 metaTitle: 'How to Build an MVP in 8 Weeks — Practical Guide | WeCcelerate',
 metaDescription:
 'Step-by-step guide to building an MVP in in adjusted timelines: how to scope, the right tech stack for 2026, scope tailored budget, success metrics, and what NOT to build. From Israel\'s leading Venture Builder.',
 speakableAnswer:
 'Building an MVP (Minimum Viable Product) takes in adjusted timelines and costs scope tailored for a typical Israeli startup. The key: choose ONE core feature that proves your value hypothesis, skip everything else, and ship to 50-100 users in 60 days. WeCcelerate builds MVPs on timelines tailored per project.js, and PostgreSQL.',
 lastUpdated: '2026-04-24',
 readingTimeMinutes: 9,
 sections: [
 {
 heading: 'What an MVP is and why it\'s critical',
 paragraphs: [
 'An MVP is the simplest version of a product that proves your core value hypothesis. The goal: not a finished product but a working artifact you can show to thousands of users and to investors. Why it\'s critical: 42% of startups fail because of "no market need" — an MVP lets you discover this after 60 days and scope tailored, not after two years and scope tailored.',
 ],
 },
 {
 heading: 'How to choose the core feature',
 paragraphs: [
 'Write down every feature you dreamed of. Now delete 90% of them. The remaining 10% — rank by "is this required for the product to deliver core value?" Only the "must-haves" go into the MVP. Everything else gets built in V2.',
 'Practical example: the Airbnb MVP was a static site with 3 listings of the founders\' apartments in San Francisco. No chat, no in-app payment, no reviews. Just a basic listing board. But it proved the hypothesis — strangers were willing to sleep at strangers\' homes. Everything else was built later.',
 ],
 },
 {
 heading: 'Tech stack for an MVP in 2026',
 paragraphs: [
 'The sweet spot for an Israeli startup in 2026: Next.js 16 + TypeScript (frontend), Node.js with Hono/Fastify (backend), PostgreSQL with Prisma (DB), Vercel (hosting), Clerk or Supabase Auth (authentication), Stripe (payments). If there\'s an AI component — OpenAI or Anthropic Claude API. This stack lets you run in production within two weeks with high reliability.',
 'Strong recommendation: don\'t mess with Kubernetes, blockchain, or "innovative" infrastructure in an MVP. Every hour invested in DevOps instead of features delays the MVP launch by a week.',
 ],
 },
 {
 heading: 'How much an MVP costs to build in Israel',
 paragraphs: [
 'Basic mobile MVP (iOS+Android) — scope tailored per project. SaaS platform MVP (web only) — scope tailored per project. Complex MVP with AI and integrations — scope tailored per project. MVP with physical hardware — scope tailored.',
 'WeCcelerate typically works on a success-fee model: full development team at reduced price in exchange for small equity, or full price when the founder prefers not to dilute. Note: we don\'t work with budgets under scope tailored — it\'s simply not realistic for the required quality.',
 ],
 },
 {
 heading: 'How to launch the MVP and measure success',
 paragraphs: [
 'MVP launch day is not the end of the journey — it\'s its beginning. First week: 50-100 limited users (Soft Launch). Weeks 2-4: public Landing Page + scope tailored Meta ads to capture feedback. Month 2: if Retention is 30%+ (Day-7) and 20%+ (Day-30) — there\'s a chance to raise Seed. If less — return to hypothesis testing.',
 ],
 },
 {
 heading: 'How WeCcelerate builds MVPs for clients',
 paragraphs: [
 'WeCcelerate process: Week 1 — scoping and technical validation. Weeks 2-6 — development in 2-week sprints. Week 7 — QA and bug fixes. Week 8 — launch. Our clients include companies that subsequently raised Seed. Our development team works in Hebrew and English, under WeCcelerate\'s CTO-as-a-Service.',
 ],
 },
 ],
 howToSteps: [
 { name: 'Define ONE value hypothesis', text: 'One sentence: "The product will help X do Y 10x better because Z". If you can\'t do this — you\'re not ready to build an MVP.' },
 { name: 'Distill the core feature', text: 'A list of 20 features? Delete 18. The remaining 2 — that\'s the MVP.' },
 { name: 'Choose a fast stack', text: 'Next.js + Node.js + PostgreSQL + Vercel. Don\'t look for innovation in infrastructure.' },
 { name: 'Set up environment in a day', text: 'Git repo, CI/CD, Vercel deploy preview — before writing code.' },
 { name: 'Develop in 2-week sprints', text: 'End of each sprint — demo to founders. Don\'t wait until the end.' },
 { name: 'Release to 50 users', text: 'Closed beta with real users — not family. Generates 10x more insights than mid-development.' },
 { name: 'Measure Retention', text: 'D1, D7, D30 retention. If <20% at D30 — there\'s a PMF problem, not an MVP problem.' },
 { name: 'Reach out to WeCcelerate', text: 'A Venture Builder team accelerates the process to just 8 weeks.', url: 'https://weccelerate.co.il/services/digital-product' },
 ],
 faqs: [
 {
 q: 'How long does it take to build an MVP?',
 a: 'in adjusted timelines is the standard range. Simple MVP (web SaaS) — in adjusted timelines. Complex MVP with native mobile and AI — in adjusted timelines.',
 },
 {
 q: 'How much does it cost to build an MVP in Israel?',
 a: 'Mobile MVP: scope tailored. Web SaaS MVP: scope tailored. Complex MVP with AI: scope tailored. Recommended minimum budget: scope tailored.',
 },
 {
 q: 'What technology should a startup use?',
 a: 'In 2026 the recommended stack: React/Next.js (frontend), Node.js or Python (backend), PostgreSQL (DB), Vercel or AWS (hosting), OpenAI/Anthropic (AI). Use proven tools, not innovative ones.',
 },
 {
 q: 'Does an MVP need to be beautiful?',
 a: 'It must be functional and not embarrassing. It doesn\'t have to be beautiful. Users are forgiving of imperfect design if the product solves a real problem.',
 },
 {
 q: 'What NOT to build in an MVP?',
 a: 'Not: an admin system, reporting system, complex Analytics, support for 10 languages, social features, Gamification, complex payments. All of these — after PMF.',
 },
 {
 q: 'Can I build an MVP without a developer?',
 a: 'Yes. No-Code tools (Bubble, Webflow, Glide, Softr) enable an MVP at half the budget. Downside: hard to scale after PMF. WeCcelerate builds proper MVPs from day one to avoid rewriting.',
 },
 ],
 relatedGuideSlugs: ['app-development-cost-israel', 'how-to-start-a-startup-israel', 'cto-as-a-service-israel'],
 ctaServicePath: '/services/digital-product',
 ctaLabel: 'We\'ll build your MVP in 8 weeks',
 },

 // ---------------------------------------------------------------------------
 // 10. CTO AS A SERVICE FOR ISRAELI STARTUPS
 // ---------------------------------------------------------------------------
 {
 slug: 'cto-as-a-service-israel',
 hebrewSlug: 'cto-as-a-service',
 category: 'product-development',
 targetKeyword: 'CTO as a Service Israel',
 relatedKeywords: [
 'fractional CTO Israel',
 'hire CTO for startup',
 'CTO as a service cost',
 'when do you need a CTO',
 'embedded CTO startup',
 ],
 h1: 'CTO as a Service for Israeli Startups: When to Hire, What It Costs, and How It Works',
 metaTitle: 'CTO as a Service Israel — Fractional CTO for Startups | WeCcelerate',
 metaDescription:
 'CTO as a Service for startups without a technical co-founder: 10-20 hours per week, architecture decisions, hiring the dev team, representing the technical side to investors. Pricing, process, when needed.',
 speakableAnswer:
 'CTO as a Service is a model where a startup without a technical founder hires a fractional CTO for 10-20 hours per week. The CTO makes architecture decisions, hires the first engineering team, reviews code, and represents the technical side to investors. WeCcelerate provides this service for Israeli startups with scope tailored per engagement.',
 lastUpdated: '2026-04-24',
 readingTimeMinutes: 6,
 sections: [
 {
 heading: 'When does a startup need CTO as a Service',
 paragraphs: [
 'Three classic situations where CTO as a Service is the right fit: (1) A strong business founder with a great idea but no technical co-founder — and unwilling to wait 6 months to recruit one. (2) A startup with a Junior CTO who needs senior guidance for a few hours per week. (3) Seed fundraising stage that requires senior technical presence in investor meetings but doesn\'t yet justify a full-time CTO.',
 ],
 },
 {
 heading: 'What CTO as a Service does in practice',
 paragraphs: [
 'WeCcelerate\'s standard role includes: architecture decisions (stack, cloud, DB), preparing the technical roadmap, hiring the first developers, weekly code reviews, technical representation in investor meetings (Technical DD), weekly meetings with the CEO. The service does NOT include writing code — that\'s the developers\' role.',
 'Clients also receive weekly Office Hours of one hour with the CTO for ad-hoc questions, and access to WeCcelerate\'s engineering network for problems that need fast solutions.',
 ],
 },
 {
 heading: 'How much it costs',
 paragraphs: [
 'CTO as a Service at WeCcelerate: scope tailored per engagement. For transitioning to a full CTO after PMF — we help with recruitment and smooth knowledge transfer.',
 'For comparison: a full-time CTO at an Israeli startup — scope tailored per month gross + 5-15% equity. CTO as a Service saves the startup scope tailored per month in the most critical phase.',
 ],
 },
 {
 heading: 'The starting process',
 paragraphs: [
 'Week 1 — kickoff meeting and assessment of current state (code, team, infrastructure). Week 2 — writing a Tech Strategy Document. Weeks 3-4 — executing critical changes (if any). From month 2 onward — ongoing operation per roadmap. Each client receives a senior CTO with at least 10 years of experience, most from leading Israeli startups.',
 ],
 },
 ],
 faqs: [
 {
 q: 'What is CTO as a Service?',
 a: 'CTO as a Service is a fractional CTO (10-20 hours/week) who works with the startup instead of a full-time CTO. They make technical decisions, hire the team, and represent the startup to investors.',
 },
 {
 q: 'When should I replace CTO as a Service with a full-time CTO?',
 a: 'Usually after Seed-Series A, when there are at least 5-10 developers on the team. WeCcelerate helps with recruitment and transfer.',
 },
 {
 q: 'How long do you work with CTO as a Service?',
 a: 'Average: over a flexible duration. Young startups work from Idea to Seed. Post-Seed startups work over a flexible duration until they hire a full-time CTO.',
 },
 {
 q: 'Does CTO as a Service write code?',
 a: 'No. The CTO is a decision-maker, not a developer. Code is written by the engineering team. The CTO ensures the code is written correctly.',
 },
 {
 q: 'Does CTO as a Service sign an NDA?',
 a: 'Always yes. Before the first meeting, we sign an NDA. The engagement contract also includes non-compete and confidentiality clauses.',
 },
 ],
 relatedGuideSlugs: ['how-to-build-mvp', 'app-development-cost-israel', 'how-to-start-a-startup-israel'],
 ctaServicePath: '/services/digital-product',
 ctaLabel: 'Talk to us about CTO as a Service',
 },

 // ---------------------------------------------------------------------------
 // 11. BUSINESS PLAN FOR STARTUPS
 // ---------------------------------------------------------------------------
 {
 slug: 'startup-business-plan',
 hebrewSlug: 'tochnit-iskit-startup',
 category: 'fundraising',
 targetKeyword: 'startup business plan',
 relatedKeywords: [
 'startup business plan template',
 'how to write a business plan',
 'investor business plan',
 'business plan vs pitch deck',
 'business plan cost',
 ],
 h1: 'Startup Business Plan: The Structure Investors Actually Read',
 metaTitle: 'Startup Business Plan — 7-Section Investor-Ready Structure | WeCcelerate',
 metaDescription:
 'How to write a startup business plan that raises funding: 7-section structure, executive summary, financial model, competitive analysis, GTM strategy. From Israel\'s leading Venture Builder.',
 speakableAnswer:
 'A typical investor-grade startup business plan is 40-80 pages with 7 sections: executive summary, market research, product description, business model, competitive analysis, team, and financial projections. WeCcelerate builds professional business plans on tailored timelines.',
 lastUpdated: '2026-04-23',
 readingTimeMinutes: 7,
 sections: [
 {
 heading: 'The 7-Section Structure',
 paragraphs: [
 'The standard structure investors expect to see, in order:',
 ],
 list: [
 'Executive Summary (2-4 pages) — summary of everything; sometimes printed on a single page',
 'Market Research (8-15 pages) — TAM/SAM/SOM, trends, target customers',
 'Product Description (5-10 pages) — what exactly you\'re building, screenshots, roadmap',
 'Business Model (5-10 pages) — how you make money, pricing, channels',
 'Competitive Analysis (5-8 pages) — who the competitors are, advantage matrix',
 'Team (2-4 pages) — who we are, why we\'re right for this',
 'Financial Projections (5-10 pages + Excel) — revenues/expenses 3-5 years',
 ],
 },
 {
 heading: 'Writing the Executive Summary',
 paragraphs: [
 'The Executive Summary is the most important section. Investors often read only it and decide whether to continue. The winning structure: Paragraph 1 — the company and the problem (4 sentences). Paragraph 2 — the solution and traction (4 sentences). Paragraph 3 — the market and opportunity. Paragraph 4 — the team. Paragraph 5 — the current round (amount, valuation, use of funds).',
 ],
 },
 {
 heading: 'Financial Model — Excel Investors Understand',
 paragraphs: [
 'A typical Seed-stage financial model: 3 years out (monthly), 6 sheets — revenues (by segment/product), CAC, LTV, employees, other expenses, cashflow. P&L and Balance Sheet. A column for each month, not just yearly summaries.',
 'Common mistakes: 10x growth projection year 1 to year 2 (unrealistic), scope tailoredB revenue in year 3 (self-aggrandizement), unexplained assumptions. An experienced Israeli investor will spot a poorly-grounded financial model in two minutes.',
 ],
 },
 {
 heading: 'Investor Business Plan vs. Bank Business Plan',
 paragraphs: [
 'A startup business plan for raising from investors differs from one submitted to a bank for a loan. For investors: emphasis on growth (10x+), venture capital, exit. For banks: emphasis on immediate profitability, repayment ability, collateral. WeCcelerate focuses on investor business plans — that\'s our domain.',
 ],
 },
 {
 heading: 'WeCcelerate\'s Process',
 paragraphs: [
 'Weeks 1-2 — interviews with founders, data gathering. Weeks 3-4 — first draft. Weeks 5-6 — 3 rounds of feedback with investor advisors. Weeks 7-8 — final polish, InDesign design. Deliverables: complete business plan (40-80 pages), Executive Summary, Excel financial model, internal presentation.',
 ],
 },
 ],
 faqs: [
 {
 q: 'How many pages should a startup business plan be?',
 a: '40-80 pages for a complete plan. An additional 2-4 page Executive Summary for investor outreach. Investors typically read only the Summary, but the full plan signals seriousness.',
 },
 {
 q: 'How is a business plan different from a Pitch Deck?',
 a: 'Pitch Deck — 10-15 slides for live presentation. Business plan — a 40-80 page text document for in-depth reading. Both are required in professional fundraising rounds.',
 },
 {
 q: 'How much does a professional business plan cost?',
 a: 'scope tailored in Israel in 2026. WeCcelerate — scope tailored per engagement. depending on scope (plan only, or plan + financial model + Pitch Deck).',
 },
 {
 q: 'Can I write a business plan myself?',
 a: 'Yes, but most founders don\'t do it well. A professional plan requires market research, financial modeling, and business writing skills — three different domains. That\'s why an accelerator engagement is worth the investment.',
 },
 {
 q: 'How long does it take to build a business plan?',
 a: 'in adjusted timelines for a professional plan. A founder working alone — over a flexible duration, with additional polish along the way.',
 },
 ],
 relatedGuideSlugs: ['startup-pitch-deck', 'raise-funding-israel', 'how-to-start-a-startup-israel'],
 ctaServicePath: '/services/business-consulting',
 ctaLabel: 'We\'ll write an investor-ready business plan',
 },

 // ---------------------------------------------------------------------------
 // 12. VESTING EXPLAINED
 // ---------------------------------------------------------------------------
 {
 slug: 'vesting-explained',
 hebrewSlug: 'vesting-hesber',
 category: 'fundraising',
 targetKeyword: 'vesting explained',
 relatedKeywords: [
 'what is vesting',
 'startup vesting',
 'vesting schedule',
 'vesting cliff',
 'founders vesting',
 'employee stock vesting',
 ],
 h1: 'Vesting Explained: How Startup Equity Vesting Actually Works',
 metaTitle: 'Vesting Explained — Cliff, Schedule, and Bad Leaver | WeCcelerate',
 metaDescription:
 'Complete guide to startup vesting: 4-year vesting with 1-year cliff, how it works for founders and employees, what happens when someone leaves. Practical guide from Israel\'s leading Venture Builder.',
 speakableAnswer:
 'Vesting is a mechanism that distributes share ownership over time. Startup standard: 4-year vesting with a 1-year cliff — if a founder leaves before a year, they get 0%. After a year — they receive 25% of the shares, and from there 1/48 per month. Vesting is critical in founder agreements and employee stock options — without it, a founder who leaves keeps 100% from the start.',
 lastUpdated: '2026-04-23',
 readingTimeMinutes: 6,
 sections: [
 {
 heading: 'What Vesting Is',
 paragraphs: [
 'Vesting is a legal mechanism that causes share ownership to "mature" over time. Without vesting, a founder who leaves the company after 6 months still owns 50% of their shares for life — a disaster.',
 'Vesting is a near-mandatory condition in fundraising. Every venture capital fund will require all founders to sign vesting before a Seed round. Without it — the round doesn\'t close.',
 ],
 },
 {
 heading: 'The Standard: 4-Year Vesting with 1-Year Cliff',
 paragraphs: [
 'The pattern recommended by every Israeli startup attorney:',
 ],
 list: [
 '4 years total — the vesting period',
 '1-year cliff — before a year passes, 0% has vested. If you leave at 11 months, you get 0%',
 'After 1 year — 25% has vested (the entire first year)',
 'From a year onward — 1/48 per month',
 'After 4 years — 100% has vested',
 ],
 },
 {
 heading: 'Numerical Example — Founder with 30%',
 paragraphs: [
 'Suppose a founder receives 30% of shares under 4/1 vesting:',
 ],
 list: [
 'Months 0-11: 0% vested (cliff). If they leave — they get nothing.',
 'Month 12: 7.5% vested (25% of 30%).',
 'Month 18: 11.25% vested.',
 'Month 24: 15% vested.',
 'Month 36: 22.5% vested.',
 'Month 48: full 30% (100%).',
 ],
 },
 {
 heading: 'Bad Leaver vs Good Leaver',
 paragraphs: [
 'What happens to unvested shares depends on the reason for leaving:',
 ],
 list: [
 'Good Leaver — leaves for legitimate reasons (illness, personal, no-fault termination). Receives the vested portion.',
 'Bad Leaver — leaves for a competitor, breach of contract, or wrongdoing. After unvested shares are returned, even vested shares may be repurchased at a low price.',
 'Bad Leaver definition must be specific in the agreement — not "any reason the board decides".',
 ],
 },
 {
 heading: 'Vesting for Employees — Same Principle',
 paragraphs: [
 'Employees who receive options (instead of direct shares) go through the same vesting process. Israeli standard: 4-year vesting with 1-year cliff. Under Section 102 of the Israeli tax code, options sign with vesting and maturity after 2 years from grant — at which point reduced taxation applies.',
 'Pool of employee options — ESOP — typically 10-20% of the company, distributed to employees over time.',
 ],
 },
 {
 heading: 'How WeCcelerate Helps with Vesting',
 paragraphs: [
 'WeCcelerate works with a network of senior Israeli startup attorneys with proven vesting templates. Our Founder Agreement at WeCcelerate includes: 4-year vesting, 1-year cliff, clean Bad Leaver clauses, and acceleration in the case of an exit. The engagement also includes explanation to the founder — important to understand what you\'re signing, not just to sign.',
 ],
 },
 ],
 faqs: [
 {
 q: 'Is vesting required?',
 a: 'Legally — no. Practically — required. Without vesting, no VC will sign a Seed round. A good attorney will refuse to file a founder agreement without vesting.',
 },
 {
 q: 'What is the cliff?',
 a: 'A period before the end of which no shares vest. If the founder leaves before the end of the cliff (typically 1 year) — they get 0%. Standard: 1-year cliff on 4-year vesting.',
 },
 {
 q: 'Does vesting apply to the lead founder (CEO)?',
 a: 'Yes. All founders sign on the same vesting. Including the founding-CEO. It\'s fair to all parties and standard at every startup.',
 },
 {
 q: 'What is "Vesting Acceleration"?',
 a: 'A scenario in which vesting accelerates — usually at exit, or if the founder is fired without fault. Types: "Single trigger" (exit = full vesting) or "Double trigger" (exit + termination). Standard: Double trigger.',
 },
 {
 q: 'Does vesting apply to investors?',
 a: 'No. Investors who purchased shares with money receive them immediately, without vesting. Vesting applies only to those who receive shares in exchange for work (founders, employees).',
 },
 ],
 relatedGuideSlugs: ['raise-funding-israel', 'how-to-start-a-startup-israel'],
 ctaServicePath: '/services/business-consulting',
 ctaLabel: 'We\'ll help you understand and sign vesting correctly',
 },

 // ---------------------------------------------------------------------------
 // 13. VENTURE VS STARTUP — THE DIFFERENCE
 // ---------------------------------------------------------------------------
 {
 slug: 'venture-vs-startup',
 hebrewSlug: 'hevdel-mizam-startup',
 category: 'comparison',
 targetKeyword: 'venture vs startup',
 relatedKeywords: [
 'difference between venture and startup',
 'what is a venture',
 'startup or venture',
 'venture vs startup definition',
 ],
 h1: 'Venture vs Startup: 7 Practical Distinctions Before You Found',
 metaTitle: 'Venture vs Startup — 7 Practical Distinctions 2026 | WeCcelerate',
 metaDescription:
 'The difference between a venture and a startup: growth model, funding model, time horizon, team type, and success metrics. 7 distinctions that help you decide which path to pursue.',
 speakableAnswer:
 'A venture is any new company searching for a business model. A startup is a sub-category of venture — specifically one aiming for exponential growth and a scope tailored exit. Every startup is a venture, but a venture can also be a stable services business or a social company. WeCcelerate is a Venture Builder and Startup Accelerator — supporting both paths.',
 lastUpdated: '2026-04-23',
 readingTimeMinutes: 5,
 sections: [
 {
 heading: 'Quick Definitions',
 paragraphs: [
 '**Venture**: Any new company or initiative that hasn\'t yet proven a stable business model. Can be a startup, but also a services business, social company, real estate venture, or cultural initiative.',
 '**Startup**: Sub-category of venture — a new company specifically aiming for exponential growth and a large exit (scope tailored). Characterized by high burn rate, search for PMF, and VC funding.',
 'Rule of thumb: every startup is a venture, but not every venture is a startup.',
 ],
 },
 {
 heading: '7 Practical Distinctions',
 paragraphs: [
 'The table below summarizes the critical differences that affect how you found, fundraise, and manage the company:',
 ],
 list: [
 'Growth model — Startup: exponential (10x+ per year). Venture: can also be linear (slowly growing company).',
 'Time horizon — Startup: 7-12 years to exit. Venture: can be open-ended (stable services company).',
 'Funding source — Startup: VC, angels, CVCs. Venture: can also be bank loan, bootstrapping, or customer revenue.',
 'Burn ratio — Startup: burns scope tailored/month sometimes without revenue. Venture: most ventures are profitable after over a flexible duration.',
 'Defined success — Startup: scope tailored exit or IPO. Venture: stable profitability, or even just ROI.',
 'Founder equity — Startup: aggressive dilution to 15-25% eventually. Venture: founders typically retain 50%+.',
 'Founder type — Startup: growth-and-risk-thirsty. Venture: can also be an experienced professional wanting autonomy.',
 ],
 },
 {
 heading: 'How to Choose — 5 Questions to Ask Yourself',
 paragraphs: [
 'The answers to these five questions will determine whether you\'re founding a startup or a venture:',
 ],
 list: [
 'Is my market scope tailored TAM? If not — not a startup.',
 'Am I willing to go 7-10 years without a full salary? If not — not a startup.',
 'Am I built to be diluted to 20% of the company by Series B? If not — venture.',
 'Can the product grow 100x without linear cost replication? If not — venture, not startup.',
 'Do I want to work 70+ hours a week for years? If not — venture at a more relaxed pace.',
 ],
 },
 {
 heading: 'In Israel — Both Paths Are Active',
 paragraphs: [
 'Israel is famous as the "Start-Up Nation" but in practice the ecosystem is one of ventures — startups and stable ventures together. Stable ventures that grew: Sapiens, Verint (like a "startup" that became a scope tailoredB public company). Classic startups: Wiz, Monday.com, Lemonade.',
 'WeCcelerate, Israel\'s leading Venture Builder, supports both paths. We support ventures that plan for IPO and ones that aim to stabilize as a successful services company.',
 ],
 },
 ],
 faqs: [
 {
 q: 'What\'s the short difference between a venture and a startup?',
 a: 'A venture is any new company. A startup is a venture specifically aiming for exponential growth and a large exit. Every startup is a venture, but not every venture is a startup.',
 },
 {
 q: 'How do I know if my idea is a venture or a startup?',
 a: 'If your market is less than scope tailored TAM, or you plan to grow linearly, or you don\'t want aggressive dilution — you\'re founding a venture, not a startup. Both are legitimate, just different funding and growth paths.',
 },
 {
 q: 'What kind does WeCcelerate build — ventures or startups?',
 a: 'Both. WeCcelerate is a Venture Builder. We support both startups aiming for IPO and ventures that want to be a stable global-scale business.',
 },
 {
 q: 'Do investors distinguish between ventures and startups?',
 a: 'Very much. VCs invest only in startups (market size scope tailored, exponential growth). Stable ventures turn to banks, private equity, or bootstrapping. Two different ecosystems, two different rule books.',
 },
 {
 q: 'Can I start as a venture and become a startup?',
 a: 'Yes, but strategically hard. If your start is a regular venture (stable services), it\'s hard to switch to exponential startup mode without changing the founding team, business model, and sometimes the corporate entity. Better to choose the right path from the start.',
 },
 ],
 relatedGuideSlugs: ['what-is-venture-builder', 'how-to-start-a-startup-israel'],
 ctaServicePath: '/services',
 ctaLabel: 'Talk to us about the right path for you',
 },
];

// =============================================================================
// HELPERS
// =============================================================================

export function getGuideBySlugEn(slug: string): GuideEn | undefined {
 return GUIDES_EN.find((g) => g.slug === slug);
}

export function getRelatedGuidesEn(guide: GuideEn): GuideEn[] {
 return guide.relatedGuideSlugs.map((slug) => getGuideBySlugEn(slug)).filter((g): g is GuideEn => Boolean(g));
}

export function getEnSlugFromHebrew(hebrewSlug: string): string | undefined {
 return GUIDES_EN.find((g) => g.hebrewSlug === hebrewSlug)?.slug;
}

export function getHebrewSlugFromEn(enSlug: string): string | undefined {
 return GUIDES_EN.find((g) => g.slug === enSlug)?.hebrewSlug;
}
